• Study on Long-Term Spesolimab Treatment for Patients with Generalized Pustular Psoriasis from Previous Trials

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Spain
  • Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    Bulgaria Estonia Hungary Latvia Lithuania Poland +1
  • Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Belgium Bulgaria France Germany Greece Hungary +8
  • Study of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Finland France Greece Italy The Netherlands Norway
  • Study on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Austria Czechia France Germany Hungary Italy +3
  • Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

    Not recruiting

    3 1 1
    Investigated Drugs:
    Bulgaria Czechia Germany Greece Latvia Poland +4
  • Study on the Effectiveness of Thyme Herb Extract, Primrose Root Tincture, and Ivy Leaf Extract for Patients with Acute Bronchitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Germany
  • Study on Alectinib and Durvalumab for Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Norway +3
  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Hungary Italy Poland Romania Spain
  • Study on the Safety and Effectiveness of Pembrolizumab and Drug Combination for Patients with Stage III Melanoma Eligible for Neoadjuvant Therapy

    Not recruiting

    1 1 1 1
    France Italy

powered by